Harvard Bioscience, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
HBIO Nasdaq 2836 www.harvardbioscience.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Harvard Bioscience, Inc.

Sidoti Events, LLC's May Micro-Cap Virtual Conference - May 20th, 2026 5:30 am
Harvard Bioscience Inc (HBIO) Q1 2026 Earnings Call Highlights: Revenue Growth Driven by New ... - May 12th, 2026 1:01 pm
Harvard Bioscience, Inc. Q1 2026 Earnings Call Summary - May 12th, 2026 11:08 am
Harvard Bioscience Announces First Quarter 2026 Financial Results - May 12th, 2026 5:30 am
Harvard Bioscience to Participate in Upcoming Investor Conferences - May 7th, 2026 5:30 am
Harvard Bioscience Schedules First Quarter 2026 Earnings Conference Call for May 12, 2026 at 8:00 AM ET - Apr 28th, 2026 5:30 am
How The Harvard Bioscience (HBIO) Investment Narrative Is Resetting After Lower 2026 Expectations - Mar 15th, 2026 9:10 pm
Harvard Bioscience Inc (HBIO) Q4 2025 Earnings Call Highlights: Strong Operational Efficiency ... - Mar 12th, 2026 1:01 pm
Harvard Bioscience, Inc. Q4 2025 Earnings Call Summary - Mar 12th, 2026 10:58 am
Harvard Bioscience (HBIO) Earnings Transcript - Mar 12th, 2026 8:19 am
Harvard Bioscience: Q4 Earnings Snapshot - Mar 12th, 2026 5:47 am
Harvard Bioscience Announces Fourth Quarter and Full-Year 2025 Financial Results - Mar 12th, 2026 5:30 am
Harvard Bioscience Announces Reverse Stock Split - Mar 6th, 2026 2:01 pm
Harvard Bioscience to Participate in KeyBanc’s Virtual Healthcare Forum - Mar 3rd, 2026 5:30 am
Harvard Bioscience Schedules Fourth Quarter 2025 Earnings Conference Call for March 12, 2026 at 8:00 AM ET - Feb 26th, 2026 5:30 am
Harvard Bioscience Announces Preliminary Fourth Quarter Financial Results, Positive Outlook for 2026 & Outlines Long-Term Strategic Focus Areas - Feb 10th, 2026 5:30 am
Harvard Bioscience will move Holliston MA manufacturing out of state - Feb 3rd, 2026 3:35 am
Harvard Bioscience Announces Strategic Consolidation of Manufacturing Operations to Improve Efficiency and Support Long-Term Growth - Jan 29th, 2026 2:30 pm
Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package - Dec 17th, 2025 5:30 am
Analysts Have Been Trimming Their Harvard Bioscience, Inc. (NASDAQ:HBIO) Price Target After Its Latest Report - Nov 9th, 2025 6:30 am